Use of botulinum toxin type A and type B for spasticity in upper and lower limbs

Physical Medicine and Rehabilitation Clinics of North America

Volumn 14, Issue 4, 2003, Pages 821-835

  Bell, Kathleen R ^a   Williams, Faren ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

ARTHRALGIA; BRAIN INJURY; CEREBRAL PALSY; ELECTROMYOGRAPHY; HEMIPLEGIA; HUMAN; MULTIPLE SCLEROSIS; MYALGIA; PARKINSON DISEASE; PHYSIOTHERAPY; PRIORITY JOURNAL; REVIEW; SPASTICITY; SPINAL CORD INJURY; STROKE; URINE RETENTION;

EID: 0141988830     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-9651(03)00064-0     Document Type: Review

References (52)

1. Das TK, Park DM. Effect of treatment with botulinum toxin on spasticity. Postgrad Med J 1989;65:208-10.
2. Das TK, Park DM. Botulinum toxin in treating spasticity. Br J Clin Pract 1989;43:401-403.
3. Gracies JM, Fitzpatrick R, Wilson L, Burke D, Gandevia SC. Lycra garments designed for patients with upper limb spasticity: mechanical effects in normal subjects. Arch Phys Med Rehabil 1997;78:1066-71.
4. Gracies JM, Wilson L, Gandevia SC, Burke D. Stretched position of spastic muscles aggravates their co-contraction in hemiplegia patients. Ann Neurol 1997;42(3):438-9.
5. Chambers HG. The surgical treatment of spasticity. Muscle Nerve Suppl 1997;6:S121-8.
6. Mittal S, Farmer JP, Al-Atassi B, et al. Functional performance following selective posterior rhizotomy: long-term results determined using a validated evaluative measure. J Neurosurg 2002;97(3):510-8.
7. Burgar CG. Electrophysiologic identification of motor points during injection of botulinum toxin: a pilot study. Arch Phys Med Rehabil 1994;75(9):1031.
8. Shaari CM, Sanders I. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis. Muscle Nerve 1993;16(9):964-9.
9. Borodic GE, Pearce LB, Smith K, Joseph M. Botulinum A toxin for spasmodic torticollis: multiple vs single injection points per muscle. Head Neck 1992;14(1):33-7.
10. Childers MK, Stacy M, Cooke DL, Stonnington HH. Comparison of two injection techniques using botulinum toxin in spastic hemiplegia. Am J Phys Med Rehabil 1996;75(6):462-9.
11. Calderon-Gonzales R, Calderon-Sepulveda R. Pathophysiology of spasticity and the role of botulinum toxin in its treatment. Acta Neuropediatr 1994;1(1):45-57.
12. Calderon-Gonzales R, Calderon-Sepulveda R, Rincon-Rayes M, Garcia-Ramirez J, Mino-Arango ME. Botulinum toxin A in the management of cerebral palsy. Pediatr Neurol 1994;10(4):284-8.
13. Cosgrove AP, Graham HK. Botulinum toxin A prevents the development of contracture in the hereditary spastic mouse. Dev Med Child Neurol 1994;36(5):379-85.
14. Ade-Hall RA, Moore AP. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. Cochrane Database Syst Rev 2000;2:CD001408.
15. Koman LA, Mooney JF, Smith BP, Walker F, Leon JM. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop 2000;20(1):108-15.
16. Ubhi T, Bhakta BB, Ives HL, Allgar V, Roussounis SH. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child 2000;83(6):481-7.
17. Corry IS, Cosgrove AP, Duffy CM, McNeill S, Taylor TC, Graham HK. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial. J Pediatr Orthop 1998;18(3):304-11.
18. Flett PJ, Stern LM, Waddy H, Connell TM, Seeger JD, Gibson SK. Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. J Paediatr Child Health 1999;35(1):71-7.
19. Thompson NS, Baker RJ, Cosgrove AP, Corry IS, Graham HK. Musculoskeletal modelling in determining the effect of botulinum toxin on the hamstrings of patients with crouch gait. Dev Med Child Neurol 1998;40(9):622-5.
20. Corry IS, Cosgrove AP, Duffy CM, Taylor TC, Graham HK. Botulinum toxin A in hamstring spasticity. Gait Posture 1999;10(3):206-10.
21. Mall V, Heinen F, Kirschner J, et al. Evaluation of botulinum toxin A in children with adductor spasm by gross motor function measure. J Child Neurol 2000;15(4):214-7.
22. Wissel J, Heinen F, Schenkel A, et al. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment. Neuropediatrics 1999;30(3):120-4.
23. Koman LA, Brashear A, Rosenfeld S, et al. Botulinum toxin type A neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. Pediatrics 2001;108(5):1062-71.
24. Gianino JM, York MM, Paice JA, Shott S. Quality of life: effect of reduced spasticity from intrathecal baclofen. J Neurosci Nurs 1998;30(1):47-54.
25. Snow BJ, Tsui JK, Bhatt MH, Varelas M, Hashimoto SA, Calne DB. Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 1990;28(4):512-5.
26. Hyman N, Barnes M, Bhakta B, et al. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatry 2000;68(6):707-12.
27. Girlanda P, Quartarone A, Sinicropi S, et al. Botulinum toxin in upper limb spasticity: study of reciprocal inhibition between forearm muscles. Neuroreport 1997;8(30):39-44.
28. Twitchell TE. The restoration of motor function following hemiplegia in man. Brain 1951;74:443-80.
29. Brashear A, Gordon MF, Elovic E, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 2002;347(6): 395-400.
30. Bakheit AM, Pittock S, Moore AP, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol 2001;8(6):559-65.
31. Hesse S, Friedrich H, Mauritz KH. Botulinum toxin therapy for upper limb flexor spasticity: preliminary results. J Rehabil Sci 1992;5(4):98-101.
32. Pierson SH, Katz DI, Tarsy D. Botulinum toxin A in the treatment of spasticity: functional limitations and patient selection. Arch Phys Med Rehabil 1996;77(7):717-21.
33. Simpson DM, Alexander DN, O'Brien CF, et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 1996;46(5):1306-10.
34. Rousseaux M, Kozlowski O, Froger J. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients. J Neurol 2002;249(1):76-84.
35. Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosurg Psychiatry 2000;69(2):217-21.
36. Smith SJ, Ellis E, White S, Moore AP. A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury. Clin Rehabil 2000;14(1):5-13.
37. Francisco GE, Boake C, Vaughn A. Botulinum toxin in upper limb spasticity after acquired brain injury: a randomized trial comparing dilution techniques. Am J Phys Med Rehabil 2002;81(5):355-63.
38. Hesse S, Krajnik J, Luecke D, Jahnke MT, Gregoric M, Mauritz KH. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke 1996;27(3):455-60.
39. Hesse S, Lucke D, Malezic M, et al. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 1994;57(11):1321-4.
40. Dengler R, Neyer U, Wohlfarth K, Bettig U, Janzik HH. Local botulinum toxin in the treatment of spastic drop foot. J Neurol 1992;239(7):375-8.
41. Burbaud P, Wiart L, Dubos JL, et al. A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry 1996;61(3):265-9.
42. Suputtitada A. Local botulinum toxin type A injections in the treatment of spastic toes. Am J Phys Med Rehabil 2002;81(10):770-5.
43. Fahn S, Elton RL. Members of the UPDRS Development Committee. In: Kolter WC, editor. Handbook of Parkinson's disease. New York: Marcel Dekker; 1987. p. 482-8.
44. Grazko MA, Polo KB, Jabbari B. Botulinum toxin A for spasticity in muscle spasms and rigidity. Neurology 1995;45:712-7.
45. Giladi N, Gurevich T, Shabtai H, Paleacu D, Simon ES. The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study. J Neurol 2001;248(7):572-6.
46. On AY, Kirazli Y, Aksit R. Mechanisms of action of phenol block and botulinus toxin type A in relieving spasticity: electrophysiologic investigation and follow-up. Am J Phys Med Rehabil 1999;78:344-9.
47. Dubinsky RM. Chemodenervation and focal limb dystonias. Paper presented at AAEM 47th Annual Scientific Meeting. Philadelphia, 2000.
48. Kirazli Y, On AY, Kismali B, Aksit R. Comparison of phenol block and botulinum toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial. Am J Phys Med Rehabil 1998;77(6):510-5.
49. Reiter F, Danni M, Lagalla G, Ceravolo G, Provinciali L. Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke. Arch Phys Med Rehabil 1998;79(5):532-5.
50. Hesse S, Reiter F, Konrad M, Jahnke MT. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial. Clin Rehabil 1998;12(5):381-8.
51. Hesse S, Jahnke MT, Luecke D, Mauritz KH. Short-term electrical stimulation enhances the effectiveness of botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett 1995;201(1):37-40.
52. Schnider P, Berger T, Schmied M, Fertl L, Auff E. Increased residual urine volume after local injection of botulinum A toxin. Nervenarzt 1995;66(6):465-7.